Advisory Committee to the Director, Centers for Disease Control (ACD, CDC), 16877-16878 [E9-8343]

Download as PDF Federal Register / Vol. 74, No. 69 / Monday, April 13, 2009 / Notices both CDC and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: April 7, 2009. Elaine L. Baker, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–8330 Filed 4–10–09; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation, Panel C, Funding Opportunity Announcement (FOA) PAR07–231 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 9 a.m.–5 p.m., April 28, 2009 (Closed). 9 a.m.–5 p.m., April 29, 2009 (Closed). Place: W Hotel, 188 14th Street, NE., Atlanta, Georgia 30361, Telephone: (404) 892–6000. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘CDC Grants for Public Health Research Dissertation, Panel C, FOA PAR07– 231.’’ Contact Person for More Information: Christine J. Morrison, PhD, Scientific Review Officer, Office of the Director, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 7, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–8333 Filed 4–10–09; 8:45 am] VerDate Nov<24>2008 18:51 Apr 10, 2009 Jkt 217001 Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention Times and Dates: 9 a.m.–5 p.m., May 14, 2009. 8:30 a.m.–3:30 p.m., May 15, 2009. Place: CDC Global Communication Center, Building 19, 1600 Clifton Road, NE., Atlanta, Georgia 30333. May 14, 2009—Building 19; Working Groups will meet as follows: Rooms 245/246—The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). Rooms 247/248—National Center for Zoonotic, Vector-Borne, and Enteric Diseases (NCZVED). Rooms 254/255—National Center for Immunization and Respiratory Diseases (NCIRD). Rooms 256/257—National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID). May 15, 2009—Full Board meets in Auditorium B3. Status: Open to the public, limited only by the space available. Purpose: The Board of Scientific Counselors, CCID, provides advice and guidance to the Director, CDC, and Director, CCID, in the following areas: program goals and objectives; strategies; program organization and resources for infectious disease prevention and control; and program priorities. Matters to be Discussed: Agenda items will include: 1. Breakout Group Discussions: Environmental Microbiology—morning session (NCPDCID and NCZVED). 2. Strategic Plan (NCPDCIC)—afternoon session. 3. Strategic Blueprint (NCZVED)— afternoon session. 4. Strategic Plan (NCHHSTP). 5. Prevention of Neonatal Group B Streptococcal Disease Influenza at the Human-Animal Interface; Review of Recommendations from April 2009 Meeting—(NCIRD). 6. Strategies for Infectious Diseases; Positioning for the Future (Full Board). 7. Budget and CCID/OD Updates. Other agenda items include announcements/introductions; follow-up on actions recommended by the Board and consideration of future directions, goals, and recommendations. Agenda items are subject to change as priorities dictate. PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 16877 Written comments are welcome and should be received by the contact person listed below prior to the opening of the meeting. Contact Person for More Information: Harriette Lynch, Office of the Director, CCID, CDC, Mailstop E–77, 1600 Clifton Road, N.E., Atlanta, Georgia 30333, e-mail: hlynch@cdc.gov; telephone (404) 498–2726. The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 6, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–8342 Filed 4–10–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director, Centers for Disease Control (ACD, CDC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC announces the following meeting of the aforementioned committee: Time and Date: 8 a.m.–3:30 p.m., April 30, 2009. Place: Centers for Disease Control and Prevention, Tom Harkin Global Communications Center, Kent ‘‘Oz’’ Nelson Auditorium, 1600 Clifton Road, NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 150 people. Purpose: The committee will provide advice to the Director, CDC on strategic and other broad issues facing CDC. Matters To Be Discussed: The committee will discuss the final report on the recommendations from the National Biosurveillance Advisory Subcommittee; discuss the mission of the Health Disparities Subcommittee; discuss the recommendations from the Ethics Subcommittee on the ‘‘Ethical Aspects of Compulsory Use of Travel Restriction Tools’’, and the subcommittee’s input on the ‘‘Role of Social Determinants Health in Health Reform’’; and will discuss CDC’s Organizational Review. Agenda items are subject to change as priorities dictate. For Further Information Contact: Brad Perkins, M.D., M.B.A., ACD, CDC, 1600 Clifton Road, NE., M/S D–14, Atlanta, Georgia 30333. Telephone 404–639–7000. The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices E:\FR\FM\13APN1.SGM 13APN1 16878 Federal Register / Vol. 74, No. 69 / Monday, April 13, 2009 / Notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 7, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–8343 Filed 4–10–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Subcommittee on Procedures Reviews, Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned subcommittee: Time and Date: 9:30 a.m.–5 p.m., May 1, 2009. Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron, Kentucky 41018, Telephone: (859) 334–4611, Fax: (859) 334– 4619. Status: Open to the public, but without a public oral comment period. To access by conference call dial the following information 1 (866) 659–0537, Participant Pass Code 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2009. Purpose: The Advisory Board is charged with (a) Providing advice to the Secretary, VerDate Nov<24>2008 18:51 Apr 10, 2009 Jkt 217001 HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee on Procedures Reviews was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. It will be responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Office of Compensation Analysis and Support (OCAS) and its dose reconstruction contractor. Matters to be Discussed: The agenda for the Subcommittee meeting includes: a discussion of proposed new versions of the computerassisted telephone interview scripts and procedures NIOSH uses to interview claimants at the outset of the dose reconstruction process; a discussion of ORAUT–OTIB–0054 (‘‘Fission and Activation Product Assignment for Internal Dose-Related Gross Beta and Gross Gamma Analyses’’), ORAUT–OTIB–0052 (‘‘Parameters for Processing Claims for Construction Workers’’); ORAU–OTIB–0029 (Internal Dosimetry Coworker Data for Y–12); and, a continuation of the commentresolution process for other dose reconstruction procedures under review by the Subcommittee. The agenda is subject to change as priorities dictate. This meeting is open to the public, but without a public oral comment period. In the event an individual wishes to provide comments, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below in advance of the meeting. Contact Person for More Information: Theodore Katz, Executive Secretary, NIOSH, CDC, 1600 Clifton Road, N.E., Mailstop E–20, Atlanta, Georgia 30333, Telephone: (513) 533–6800, Toll Free 1 (800) CDC–INFO, email ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 3, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–8335 Filed 4–10–09; 8:45 am] BILLING CODE 4163–19–P PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Injury Prevention and Control, Initial Review Group, (NCIPC, IRG) Correction: This notice was published in the Federal Register on March 30, 2009, Volume 74, Number 59, Page 14134. The times and place for the aforementioned meeting have been changed to the following: Times and Dates: 10 a.m.–10:30 a.m., April 22, 2009 (Open). 10:30 a.m.–5 p.m., April 22, 2009 (Closed). Place: Teleconference, toll free: (888)793– 2154, Participant Passcode: 4424802. Contact Person for More Information: Jane Suen, Dr. P.H., M.S., NCIPC, CDC, 4770 Buford Highway, NE., Mailstop F–62, Atlanta, Georgia 30341, Telephone: (770) 488–4281. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 3, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–8331 Filed 4–10–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel Member Conflict. Date: May 5, 2009. E:\FR\FM\13APN1.SGM 13APN1

Agencies

[Federal Register Volume 74, Number 69 (Monday, April 13, 2009)]
[Notices]
[Pages 16877-16878]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-8343]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director, Centers for Disease Control 
(ACD, CDC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), CDC announces the following meeting of 
the aforementioned committee:

    Time and Date: 8 a.m.-3:30 p.m., April 30, 2009.
    Place: Centers for Disease Control and Prevention, Tom Harkin 
Global Communications Center, Kent ``Oz'' Nelson Auditorium, 1600 
Clifton Road, NE., Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 150 people.
    Purpose: The committee will provide advice to the Director, CDC 
on strategic and other broad issues facing CDC.
    Matters To Be Discussed: The committee will discuss the final 
report on the recommendations from the National Biosurveillance 
Advisory Subcommittee; discuss the mission of the Health Disparities 
Subcommittee; discuss the recommendations from the Ethics 
Subcommittee on the ``Ethical Aspects of Compulsory Use of Travel 
Restriction Tools'', and the subcommittee's input on the ``Role of 
Social Determinants Health in Health Reform''; and will discuss 
CDC's Organizational Review.
    Agenda items are subject to change as priorities dictate.
    For Further Information Contact: Brad Perkins, M.D., M.B.A., 
ACD, CDC, 1600 Clifton Road, NE., M/S D-14, Atlanta, Georgia 30333. 
Telephone 404-639-7000. The Director, Management Analysis and 
Services office has been delegated the authority to sign Federal 
Register notices

[[Page 16878]]

pertaining to announcements of meetings and other committee 
management activities for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

    Dated: April 7, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-8343 Filed 4-10-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.